Representative imaging from a patient with bilateral NF2-related VSs and a patient with chondrosarcoma is shown in Fig. 6 and demonstrates the more heterogenous post GBCA enhancement within the imaged chondrosarcoma cohort and the much larger difference in SFE within the chondrosarcoma tumour region between the low-dose and full-dose acquisition. This evidence concerns the gene NF2 and neoplasm.